Pharmaceutical industry news

Alnylam Pharmaceuticals Inc Stock (ALNY) Moved Up by 7.90% on Sep 2: Facts Behind the Movement

What Novartis's $3.2 Billion Enzyme Licensing Deal Means for Formulation

“If there’s a will, there’s a way,” says FSSAI chief backing Tukaram Mundhe’s crackdown in Maharashtra

Kidney Health Guidance on Cardiovascular-Kidney-Metabolic (CKM) Syndrome

Asian data face global test in biotech deals

FDA issues red alert for US heart pump system

Charité erhält vor Berliner Arbeitsgericht wegen Notdienstvereinbarung recht

Can-Fite BioPharma Evaluates Earlier Interim Analysis for Key Liver Cancer Study

How Is Vertex Pharmaceuticals' Stock Performance Compared to Other Biotech Stocks?

When Payers Know the Price of Everything

Septembre en or au CHU de Toulouse

Krystal Biotech (KRYS) Up 12% Since Last Earnings Report: Can It Continue?

HSV-1 Keratitis Clinical Trial Pipeline Analysis: 3+ Key

India busts firm faking expiry dates, nutrition labels on PepsiCo, Nestle food exports

WorkWell

Information on WorkWell for local systems partnerships.

Auchincloss: US Biotech's Biggest Threat Isn't Beijing — It's Washington

What the Independent Pharmacy Cooperative Acquisition of USave Pharmacy Group Signals

R-CCS adopts quantum software development kit from QunaSys

Lilly’s Merida Deal Shows the GLP-1 King Is Already Thinking Beyond Obesity

FIFARMA W.A.I.T. Indicator 2026: del tiempo de espera a la oportunidad de avanzar

Maharashtra FDA steps up Mumbai inspections; Goregaon, Kurla eateries and Chembur bakeries face action

Teva autoimmune antibody notches ph. 2 win in celiac disease

Teva's immune disorder drug meets main goal in mid-stage trial

Purple Biotech Jumps After New U.S. Patent Allowance for CAPTN-3 Platform

TScan axes 75% of staff to make room for solid tumor programs

Teva claims success in celiac study; BioMarin, Ascendis settle patent dispute

State challenge to policy permitting mifepristone by mail paused until after midterms. Published Sep. 2 2026. Nation.

FDA approves landmark pancreatic cancer drug

Medienmitteilung: Gesundheitskommissionen verlangen Kurskorrektur bei der KVV-Revision

The Next Generation of Pharmaceutical Logistics: Personalization, Cold Chain Expansion and Elevated Resilience

Farewell black spruce? How climate change and pests are reshaping North America’s forests

No evidence for modulation of the readiness potential by respiratory phase during natural breathing

How the brain dances across critical boundaries

Roundup: Alteogen Enters Option & License Agreement with Novartis, NewBiologix & Synastra Form BioTech Partnership, RedHill Acquires Commercialization Rights to Rebyota & Clenpiq

Cook Medical sets target to reduce greenhouse gas emissions 35% by 2035

Pharmacist training sites to receive backdated funding uplift

ARPA-H funds biotechs working on custom RNA therapies

Are Investors Undervaluing Takeda Pharmaceutical Co. (TAK) Right Now?

Protocol Amendment Checklist for Sponsors

Improving Protocol Amendment Execution Through Site-Sponsor Alignment

Why Is Purple Biotech Stock Gaining Wednesday?

Pesticide Found in Supplement; Brain-Eating Amoeba Kills Teen; B12 and Birth Defects

Hansa CEO Aguiar-Lucander: U.S. Listing Is Not Optional for European Biotech

Can-Fite Announces Exercise of Warrants for Approximately $4.0 Million in Gross Proceeds

Relevate Health and Flora Health launch formulary capability for pharmaceutical brands

The biotech bi-weekly: designing preclinical oncology programs, mass spectrometers with an isotope ratio analysis mode and single-molecule mutation sequencing

Can-Fite BioPharma (CANF) halves warrant price in cash-for-warrants deal

Federal judge pauses case on abortion pill access until after midterm elections

Biocytogen Enters into Non-Exclusive Licensing Agreement with Qilu Pharmaceutical for a Fully Human VHH Antibody to Support Innovative Drug Development in Neuroscience

Can-Fite Announces Exercise of Warrants for Approximately $4.0 Million in Gross Proceeds

BioMarin to Participate in Upcoming Investor Conferences

Purple Biotech (PPBT) Secures Key Patent Allowance for Tri-Specific Antibody Platform

From Pandemic Prevention to Pharmaceutical Resilience: Why Health Security Should Be Part of US-Taiwan Economic Security Cooperation

Veru to Participate in Fireside Chat at the 2026 Cantor Global Healthcare Conference

REG - Hikma Pharmaceutical - Holding(s) in Company

Federal judge makes big call on major abortion medication case amid FDA review

Immunic to Host Virtual Relapsing Multiple Sclerosis R&D Day on September 9, 2026

The FDA Has Put Its Strongest Warning on a Common Iron Infusion Over Dangerously Low Phosphate

8-K: Report of unscheduled material events or corporate event

Purple Biotech PPBT Slides As Cash Crunch Shadows Preclinical Progress